emilianomorfin

Posición de extremo riesgo

Long
emilianomorfin Updated   
NASDAQ:CRIS   Curis, Inc.
Soporte fuerte, posición riesgosa dado su dependencia a noticias.
Trade active
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.